返回
Aspira Women's Health Inc（AWHL）价格
AWHL 股价走势图
AWHL 收益
Aspira Women's Health Inc
$0.42
-6.11%
$-0.02
截至今日：Jan 26, 12:30:40 GMT-5
最新收益结果： Q3 '24
报告： 2024-11-19
历史收益
季度性
年度
EPS
收入
Earnings FAQ
AWHL 最近的每股收益与预期相比如何？
Aspira Women's Health Inc AWHL 上一季度的收入表现如何？
Aspira Women's Health Inc 的收入预期是多少？
Aspira Women's Health Inc 的盈利质量评分是多少？
Aspira Women's Health Inc 何时发布财报？
Aspira Women's Health Inc 的预期收益是多少？
Aspira Women's Health Inc 是否超出收益预期？
关键数据
前收盘价
$0.45
开盘价
$0.4201
当日区间
$0.4201 - $0.4225
52周范围
$0.02 - $0.71
交易量
8.0K
平均成交量
66.5K
每股收益（TTM）
-0.99
股息收益率
--
市值
$18.0M
什么是 AWHL？
Aspira Women's Health, Inc. engages in the provision of bio-analytic and diagnostic services. The company is headquartered in Austin, Texas and currently employs 66 full-time employees. The company went IPO on 2000-09-29. The firm's portfolio includes OvaWatch and the Ova1Plus workflow, offered to clinicians as OvaSuite. OvaWatch is used to assess ovarian cancer risk for women with an adnexal mass where their initial clinical assessment indicates the mass is indeterminate or benign. The Ova1Plus is a reflex process of two tests, Ova1 and Overa, to assess the risk of ovarian malignancy in women with an adnexal mass planned for surgery. Its product pipelines are OVAinform and ENDOinform. OVAinform is a test that combines serum proteins, clinical data (metadata), and miRNA for assessing the risk of ovarian cancer in women with an adnexal mass. ENDOinform is a test program that combines serum proteins, clinical data (metadata), and miRNA for the identification of endometriosis.